Adjuvant radiation therapy in metastatic lymph nodes from melanoma

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Bibault, Jean Emmanuel ^a   Dewas, Sylvain ^a   Mirabel, Xavier ^a   Mortier, Laurent ^b   Penel, Nicolas ^c   Vanseymortier, Luc ^c   Lartigau, Eric ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CUTANEOUS MELANOMA; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; ADJUVANT THERAPY; ADOLESCENT; EVALUATION; LYMPH NODE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIATION EXPOSURE; RETROSPECTIVE STUDY; SKIN TUMOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79551575836     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-12     Document Type: Article

References (34)

1. Hughes TMD, Ahern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000, 87(7):892-901. 10.1046/j.1365-2168.2000.01439.x, 10931025.
2. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. New England Journal of Medicine 2004, 351(10):998. 10.1056/NEJMra041245, 15342808.
3. Lens MB, Dawes M. Interferon Alfa Therapy for Malignant Melanoma: A Systematic Review of Randomized Controlled Trials. J Clin Oncol 2002, 20(7):1818-1825. 10.1200/JCO.2002.07.070, 11919239.
4. Messina JL, Glass LF, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Path 1999, 23(6):686. 10.1097/00000478-199906000-00008, 10366151.
5. Rutkowski P, Nowecki ZI, Nasierowska-Guttmejer A, Ruka W. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact. Eur J Surg Onc 2003, 29(7):611-618.
6. Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human malignant melanoma cells grown in vitro. Cancer Research 1971, 31(6):830.
7. Stevens G, McKay MJ. Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. The Lancet Oncology 2006, 7(7):575-583. 10.1016/S1470-2045(06)70758-6, 16814209.
8. Ballo MT, Zagars GK, Gershenwald JE. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann of Surg Onc 2004, 11(12):1079-1084.
9. Ballo MT, Ross MI, Cormier JN. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 2006, 64(1):106-113. 10.1016/j.ijrobp.2005.06.030, 16182463.
10. Ballo MT, Bonnen MD, Garden AS. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 2003, 97(7):1789-1796. 10.1002/cncr.11243, 12655537.
11. Beadle BM, Guadagnolo BA, Ballo MT. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 2009, 73(5):1376-1382. 10.1016/j.ijrobp.2008.06.1910, 18774657.
12. Strojan P, Jancar B, Cemazar M, Perme MP, Hocevar M. Melanoma Metastases to the Neck Nodes: Role of Adjuvant Irradiation. Int J Radiat Oncol Biol Phys 2010, 77(4):1039-1045. 10.1016/j.ijrobp.2009.06.071, 19910139.
13. Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis Ann Surg 1991, 214(5):627-636.
14. Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Brennan MF. Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg 1990, 212(2):125-131. 10.1097/00000658-199008000-00002, 1358045, 2375645.
15. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 1986, 73(11):906-908. 10.1002/bjs.1800731119, 3790922.
16. Byers RM. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arc of Surg 1986, 121(11):1338.
17. Lee RJ, Gibbs JF, Proulx GM. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2000, 46(2):467-474. 10.1016/S0360-3016(99)00431-9, 10661355.
18. O'brien CJ, Coates AS, Petersen-Schaefer K. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991, 162(4):310.
19. Shen P, Wanek LA, Morton DL. Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?. Ann of Surg Onc 2000, 7(8):554-559.
20. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arc of Surg 1989, 124(9):1051.
21. Moncrieff MD, Martin R, O'Brien CJ. Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients?. Ann of Surg Onc 2008, 15(11):3022-3027.
22. Pidhorecky I, Lee RJ, Proulx G. Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann of Surg Onc 2001, 8(2):109-115.
23. Karakousis CP, Hena MA, Emrich LJ. Axillary node dissection in malignant melanoma: results and complications. Surgery 1990, 108(1):10.
24. Starritt EC, Joseph D, McKinnon JG. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg 2004, 240(5):866. 10.1097/01.sla.0000143271.32568.2b, 1356494, 15492570.
25. Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arc of Surg 1992, 127(12):1412.
26. Allan CP, Hayes AJ, Thomas JM. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. J Surg 2008, 78(11):982.
27. Karakousis CP, Driscoll DL, Rose B. Groin dissection in malignant melanoma. Ann of Surg Onc 1994, 1(4):271-277.
28. Strobbe LJ, Jonk A, Hart AA. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann of Surg Onc 1999, 6(3):255-262.
29. Urist MM, Maddox WA, Kennedy JE. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Can J Clin 2006, 51(11):2152-2156.
30. Rofstad EK, Wahl A, Brustad T. Radiation sensitivity in vitro of cells isolated from human tumor surgical specimens. Can Res 1987, 47(1):106.
31. Bentzen SM, Overgaard J, Thames HD. Clinical radiobiology of malignant melanoma. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 1989, 16(3):169.
32. McKay MJ, Kefford RF. The spectrum of in vitro radiosensitivity in four human melanoma cell lines is not accounted for by differential induction or rejoining of DNA double strand breaks. Int J Radiat Oncol Biol Phys 1995, 31:345-345. 10.1016/0360-3016(94)E0147-C, 7836088.
33. Overgaard J, Overgaard M, Hansen PV. Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol 1986, 5(3):183. 10.1016/S0167-8140(86)80048-2, 3085169.
34. Sause WT, Cooper JS, Rush S. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991, 20(3):429. 10.1016/0360-3016(91)90053-7, 1995527.